Table 5:

Univariate analyses of time to progression with death as competing risk

Parameter	p-value	sHR	95%CI
Age	0.51	0.99	0.95, 1.02
Sex
Male
Female	0.72	1.12	0.59, 2.12
Stage	<0.001	1.46	1.26, 1.69
Tumor size (log)	0.013	8.28	1.57, 43.7
Surgery
Limited resection (LR)
Lobectomy (LO)	0.52	0.82	0.45, 1.50
Histologic subtype at biopsy
Non MIP-SOL
MIP-SOL	<0.001	3.43	1.84, 6.39